Who
Timothy C. Barabe
Director
Company insider
Files Form 4 as: Director, Heartflow; Director, Cartesian Therapeutics; Director, Veeva Systems; Director, Arqule; Director, Opexa Therapeutics; Chief Financial Officer, Affymetrix; Chief Financial Officer, Human Genome Sciences.
In numbers
- Trades disclosed
- 388
- Buys
- 79
- Sells
- 16
- Bought
- $1.2M
- Sold
- $4.8M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 14 Mar 2006
- Last trade
- 22 Jul 2026
- Last filed
- 24 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jul 2026filed 24 Jul 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $70K3,710 at $19.00 | filing |
| 22 Jul 2026filed 24 Jul 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,710 at $0.00 | filing |
| 22 Jul 2026filed 24 Jul 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,710 at $0.00 | filing |
| 22 Jul 2026filed 24 Jul 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $70K3,710 at $19.00 | filing |
| 17 Jul 2026filed 20 Jul 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $95K5,000 at $19.00 | filing |
| 17 Jul 2026filed 20 Jul 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 17 Jul 2026filed 20 Jul 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 17 Jul 2026filed 20 Jul 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $95K5,000 at $19.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code A | $515K16,075 at $32.05 | filing |
| 16 Jun 2026filed 18 Jun 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code A | $515K16,075 at $32.05 | filing |
| 11 Mar 2026filed 12 Mar 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $19K8,667 at $2.22 | filing |
| 11 Mar 2026filed 12 Mar 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —8,667 at $0.00 | filing |
| 11 Mar 2026filed 12 Mar 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —8,667 at $0.00 | filing |
| 11 Mar 2026filed 12 Mar 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $19K8,667 at $2.22 | filing |
| 17 Feb 2026filed 19 Feb 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $21K2,497 at $8.33 | filing |
| 17 Feb 2026filed 19 Feb 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,497 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,497 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $21K2,497 at $8.33 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,600 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.